06108 Relative Valuation
06108's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, 06108 is overvalued; if below, it's undervalued.
Historical Valuation
NEW RAY MEDIC (06108) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of NEW RAY MEDIC (06108) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：0.28
Fair
0.00
PE
1Y
3Y
5Y
0.00
EV/EBITDA
NEW RAY MEDIC. (06108) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.00
EV/EBIT
NEW RAY MEDIC. (06108) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.
0.00
PS
NEW RAY MEDIC. (06108) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.
0.00
P/OCF
NEW RAY MEDIC. (06108) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.
0.00
P/FCF
NEW RAY MEDIC. (06108) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
NEW RAY MEDIC (06108) has a current Price-to-Book (P/B) ratio of 0.16. Compared to its 3-year average P/B ratio of 0.58 , the current P/B ratio is approximately -73.05% higher. Relative to its 5-year average P/B ratio of 0.58, the current P/B ratio is about -73.05% higher. NEW RAY MEDIC (06108) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -12.39%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -12.39% , the current FCF yield is about -100.00% lower.
0.16
P/B
Median3y
0.58
Median5y
0.58
0.00
FCF Yield
Median3y
-12.39
Median5y
-12.39
Performance Decomposition
1Y
3Y
5Y
Market capitalization of 06108 increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of 06108 in the past 1 year is driven by Unknown.
People Also Watch
TSLA
Tesla Inc
435.8USD
1.02%
WMT
Walmart Inc
113.07USD
0.31%
XOM
Exxon Mobil Corp
122.91USD
3.73%
AAPL
Apple Inc
259.04USD
-0.50%
AVGO
Broadcom Inc
332.48USD
-3.21%
MSFT
Microsoft Corp
478.11USD
-1.11%
NVDA
NVIDIA Corp
185.04USD
-2.15%
ORCL
Oracle Corp
189.65USD
-1.65%
AMZN
Amazon.com Inc
246.26USD
1.95%
META
Meta Platforms Inc
646.06USD
-0.41%
Frequently Asked Questions
Is NEW RAY MEDIC (06108) currently overvalued or undervalued?
NEW RAY MEDIC (06108) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of NEW RAY MEDIC (06108) is between to according to relative valuation methord.
What is NEW RAY MEDIC (06108) fair value?
06108's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of NEW RAY MEDIC (06108) is between to according to relative valuation methord.
How does 06108's valuation metrics compare to the industry average?
The average P/S ratio for 06108's competitors is , providing a benchmark for relative valuation. NEW RAY MEDIC Corp (06108) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for NEW RAY MEDIC (06108) as of Jan 08 2026?
As of Jan 08 2026, NEW RAY MEDIC (06108) has a P/B ratio of 0.16. This indicates that the market values 06108 at 0.16 times its book value.
What is the current FCF Yield for NEW RAY MEDIC (06108) as of Jan 08 2026?
As of Jan 08 2026, NEW RAY MEDIC (06108) has a FCF Yield of 0.00%. This means that for every dollar of NEW RAY MEDIC’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for NEW RAY MEDIC (06108) as of Jan 08 2026?
As of Jan 08 2026, NEW RAY MEDIC (06108) has a Forward P/E ratio of 0.00. This means the market is willing to pay $0.00 for every dollar of NEW RAY MEDIC’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for NEW RAY MEDIC (06108) as of Jan 08 2026?
As of Jan 08 2026, NEW RAY MEDIC (06108) has a Forward P/S ratio of 0.00. This means the market is valuing 06108 at $0.00 for every dollar of expected revenue over the next 12 months.